FDA Inspection 807610 — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC — FEI 1000115163

The FDA completed an inspection of Fresenius Kabi USA, LLC on November 20, 2012 in Melrose Park, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 20, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Melrose Park, IL (United States)